For the Inventor, By the Inventor

Enter assignee name

Seattle, WA, United States of America

Corixa Corporation

USPTO Granted Patents = 247

% Expired Patents = 32.4

CIPO Patents = 11

EPO Patents = 26

Forward Citations = 3,347

Loading Chart...

Loading Chart...

131 inventors (with patents filed for the assignee):

Steven G Reed (84 out of 146 patents)

Davin C Dillon (76 out of 76 patents)

Michael J Lodes (48 out of 48 patents)

4. Yasir A W Skeiky (48 out of 49 patents)

5. Jiangchun Xu (47 out of 55 patents)

6. Jennifer L Mitcham (38 out of 60 patents)

7. Raymond L Houghton (35 out of 41 patents)

8. Yasir A Skeiky (34 out of 34 patents)

9. Gary R Fanger (34 out of 35 patents)

10. Antonio Campos-Neto (31 out of 31 patents)

11. Thomas S Vedvick (30 out of 50 patents)

12. Marc W Retter (30 out of 31 patents)

13. Susan L Harlocker (24 out of 24 patents)

14. Tongtong Wang (24 out of 25 patents)

15. Michael D Kalos (22 out of 22 patents)

Core Competencies:

Inflammatory Bowel Disease

Immunotherapy

Cancer Diagnosis

Tumor Antigens

Chlamydial Infection

Prostate Cancer

Breast Cancer

Ovarian Cancer

Fusion Proteins

Hematological Malignancies

Tuberculosis

Immunoeffector Compounds

247 patents: Sort by Forward Citations

1. 10981978 - Compositions and methods for the therapy and diagnosis of Inflammatory Bowel Disease (2021-04-20),

2. 10457722 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2019-10-29),

3. 10011650 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2018-07-03),

4. 9868779 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2018-01-16),

5. 9512159 - Methods for the production of 3-O-deactivated-4'-monophosphoryl lipid A (3D-MLA) (2016-12-06),

6. 9290543 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2016-03-22),

7. 9175046 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2015-11-03),

8. 8920776 - Compositions and methods for the detection diagnosis and therapy of hematological malignancies (2014-12-30),

9. 8541007 - Vaccines against chlamydial infection (2013-09-24),

10. 8318901 - Compositions and methods for the therapy and diagnosis of inflammatory bowel disease (2012-11-27),

11. 8318697 - Prophylactic and therapeutic treatment of infectious and other diseases with mono- and disaccharide-based compounds (2012-11-27),

12. 8263089 - Compounds and methods for treatment and diagnosis of chlamydial infection (2012-09-11),

13. 8182823 - Compositions and methods for the therapy and diagnosis of breast cancer (2012-05-22),

14. 8143386 - [object Object] (2012-03-27),

15. 8110201 - Fusion proteins of mycobacterium tuberculosis (2012-02-07),

Corixa Corporation, based in Seattle, WA, specializes in the development of innovative immunotherapy solutions aimed at treating various diseases, including inflammatory bowel disease and different types of cancer. The company focuses on harnessing tumor antigens and advancing diagnostic methods to enhance cancer detection and treatment. With a commitment to addressing complex health challenges, Corixa is actively engaged in research related to chlamydial infections and specific cancers such as prostate, breast, and ovarian cancer.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

247 Patents

#10 in Seattle, WA

#30 in Washington

#1,727 in US

#3,514 in the World

Seattle, WA, United States of America

Corixa Corporation

Forward Citations = 3,347

131 inventors:

Steven G Reed (84 out of 146 patents)

Davin C Dillon (76 out of 76 patents)

Michael J Lodes (48 out of 48 patents)

4. Yasir A W Skeiky (48 out of 49 patents)

5. Jiangchun Xu (47 out of 55 patents)

Please report any incorrect information to [email protected]

Loading…